Akhil P. Santhosh
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study.
Journal: Frontiers in pharmacology
Published: October 25, 2025
Nivolumab plus Ipilimumab in Advanced Melanoma.
Journal: The New England journal of medicine
Published: March 26, 2025
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH study.
Journal: Ecancermedicalscience
Published: February 19, 2025
Doxorubicin-Trabectedin in Leiomyosarcoma.
Journal: The New England journal of medicine
Published: November 27, 2024
Pretransplantation optimisation for unresectable colorectal liver metastases: the TransMet trial.
Journal: Lancet (London, England)
Published: October 30, 2024
Succinate dehydrogenase deficient GIST: Case series and review of literature from a tertiary care center in India.
Journal: Indian journal of cancer
Published: July 06, 2024
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2024
Quality of life assessment in testicular non-seminomatous germ cell tumour survivors.
Journal: Journal of cancer survivorship : research and practice
Published: March 08, 2023
Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).
Journal: Trials
Published: September 15, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026